Cytokine gene polymorphism in human disease: On-line databases, supplement 2

Genes and Immunity

Volumn 3, Issue 6, 2002, Pages 313-330

  Haukim, N ^a   Bidwell, Jeff L ^a   Smith, A J P ^a   Keen, L J ^a   Gallagher, G ^b   Kimberly, R ^c   Huizinga, T ^d   McDermott, M F ^e   Oksenberg, J ^f   McNicholl, J ^g   Pociot, F ^h   Hardt, C ⁱ   D'Alfonso, S ^j  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ROYAL LONDON HOSPITAL   (United Kingdom)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g Immunology Branch   (United States)

^h STENO DIABETES CENTER   (Denmark)

ⁱ UNIVERSITY HOSPITAL ESSEN   (Germany)

^j UNIVERSITY OF EASTERN PIEDMONT   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

DATA BASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEDLINE; NUCLEOTIDE SEQUENCE; PHYSICAL DISEASE; PRIORITY JOURNAL; PUBLICATION; REVIEW; GENETIC DATABASE; GENETIC DISORDER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; NOTE;

CYTOKINES; DATABASES, GENETIC; GENETIC DISEASES, INBORN; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC;

EID: 0012205654     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363881     Document Type: Review

References (284)

1. Bidwell J, Keen L, Gallagher G, Kimberley R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999; 1: 1-17.
2. Bidwell J, Keen L, Gallagher G, Kimberley R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S. Cytokine gene polymorphism in human disease: on-line databases, Supplement 1. Genes Immun 2001; 2: 61-70.
3. Bidwell JL, Wood NA, Morse HR, Olomolaiye OO, Laundy GJ. Human cytokine gene nucleotide sequence alignments, 1998. Eur J Immunogenet 1998; 25: 83-265.
4. Iwasaki H, Ota N, Nakajima T, Shinohara Y, Kodaira M, Kajita M, Emi M. Five novel single-nucleotide polymorphisms of human interferon gamma identified by sequencing the entire gene. J Hum Genet 2001; 46: 32-34.
5. Muldoon J, Uriel A, Khoo S, Ollier WE, Hajeer AH. Novel IFN-alpha receptor promoter polymorphisms. Genes Immun 2001; 2: 159-60.
6. Bergholdt R, Larsen ZM, Andersen NA et al. Characterization of new polymorphisms in the 5′ UTR of the human interleukin-1 receptor type 1 (IL1R1) gene: linkage to type 1 diabetes and correlation to IL-1RI plasma level. Genes Immun 2000; 1: 495-500.
7. Sitara D, Olomolaiye O, Wood N et al. Identification of novel single nucleotide polymorphisms in intron 1B and exon 1C of the human interleukin-1 receptor type 1 (IL-1R1) gene. Genes Immun 1999; 1: 161-163.
8. Sitara D, Wood N, Morse H, Keen L, Bidwell J. A Bsr BI polymorphism in exon 1C of the human interleukin-1 receptor type I (IL-1RI) gene. Genes Immun 2000; 1: 234-235.
9. Sitara D, Wood N, Keen L, Morse H, Bidwell J. Characterization of a rare sty I polymorphism in exon 1C of the human interleukin-1 receptor type I (IL-1RI) gene. Eur J Immunogenet 2000; 27: 103-104.
10. Khani-Hanjani A, Hoar D, Horsman D, Lacaille D, Chalmers A, Keown P. Identification of four novel dinucleotide repeat polymorphisms in the IL-2 and IL-2beta receptor genes. Hum Immunol 2001; 62: 368-370.
11. Lozano F, Places L, Vila JM et al. Identification of a novel single-nucleotide polymorphism (Va1554Ile) and definition of eight common alleles for human IL4RA exon 11. Tissue Antigens 2001; 57: 216-220.
12. Hackstein H, Hecker M, Kruse S et al. A novel polymorphism in the 5′ promoter region of the human interleukin-4 receptor alpha-chain gene is associated with decreased soluble interleukin-4 receptor protein levels. Immunogenetics 2001; 53: 264-269.
13. Gibson AW, Edberg JC, Wu J, Westendorp RG, Huizinga TW, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol 2001; 166: 3915-3922.
14. D'Alfonso S, Rampi M, Rolando V, Giordano M, Momigliano-Richiardi P. New polymorphisms in the IL-10 promoter region. Genes Immun 2000; 1: 231-233.
15. Donger C, Georges JL, Nicaud V et al. New polymorphisms in the interleukin-10 gene - relationships to myocardial infarction. Eur J Clin Invest 2001; 31: 9-14.
16. Kube D, Rieth H, Eskdale J, Kremsner PG, Gallagher G. Structural characterisation of the distal 5′ flanking region of the human interleukin-10 gene. Genes Immun 2001; 2: 181-190.
17. Pravica V, Brogan IJ, Hutchinson IV. Rare polymorphisms in the promoter regions of the human interleukin-12 p35 and interleukin-12 p40 subunit genes. Eur J Immunogenet 2000; 27: 35-36.
18. Hall MA, McGlinn E, Coakley G et al. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun 2000; 1: 219-224.
19. Huang D, Cancilla MR, Morahan G. Complete primary structure, chromosomal localisation, and definition of polymorphisms of the gene encoding the human interleukin-12 p40 subunit. Genes Immun 2000; 1: 515-520.
20. Pantelidis P, Jones MG, Welsh KI, Taylor AN, du Bois RM. Identification of four novel interleukin-13 gene polymorphisms. Genes Immun 2000; 1: 341-345.
21. Liu X, Nickel R, Beyer K et al. An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol 2000; 106: 167-170.
22. Graves PE, Kabesch M, Halonen M et al. A cluster of seven tightly linked polymorphisms in the IL-13 gene is associated with total serum IgE levels in three populations of white children. J Allergy Clin Immunol 2000; 105: 506-513.
23. Ahmed S, Ihara K, Sasaki Y et al. Novel polymorphism in the coding region of the IL-13 receptor Alpha' gene: association study with atopic asthma in the japanese population. Exp Clin Immunogenet 2000; 17: 18-22.
24. Nakayama EE, Wasi C, Ajisawa A, Iwamoto A, Shioda T. A new polymorphism in the promoter region of the human interleukin-16 (IL-16) gene. Genes Immun 2000; 1: 293-294.
25. Giedraitis V, He B, Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001; 112: 146-152.
26. Azzawi M, Pravica V, Hasleton PS, Hutchinson IV. A single nucleotide polymorphism at position -109 of the RANTES proximal promoter. Eur J Immunogenet 2001; 28: 95-96.
27. Alansari A, Hajeer AH, Bayat A, Eyre S, Carthy D, Ollier WE. Two novel polymorphisms in the human transforming growth factor beta 2 gene. Genes Immun 2001; 2: 295-296.
28. Eskdale J, Turestkaya RL, Armstrong C, Kuprash DV, Nedospasov SA, Gallagher G. A polymorphic microsatellite marker in the human p55 TNF receptor, CD120a. Genes Immun 2000; 1: 228-230.
29. Kilpinen S, Hulkkonen J, Wang XY, Hurme M. The promoter polymorphism of the interleukin-6 gene regulates interleukin-6 production in neonates but not in adults. Eur Cytokine Netw 2001; 12: 62-68.
30. Kaijzel E, Bayley JP, van Krugten M et al. Allele-specific quantification of tumor necrosis factor alpha (TNF) transcription and the role of promoter polymorphisms in rheumatoid arthritis patients and healthy individuals. Genes Immun 2001; 2: 135-144.
31. Kaluza W, Reuss E, Grossmann S et al. Different transcriptional activity and in vitro TNF-alpha production in psoriasis patients carrying the TNF-alpha 238A promoter polymorphism. J Invest Dermatol 2000; 114: 1180-1183.
32. Hohjoh H, Tokunaga K. Allele-specific binding of the ubiquitous transcription factor OCT-1 to the functional single nucleotide polymorphism (SNP) sites in the tumor necrosis factor-alpha gene (TNFA) promoter. Genes Immun 2001; 2: 105-109.
33. Luedecking EK, DeKosky ST, Mehdi H, Ganguli M, Kamboh MI. Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease. Hum Genet 2000; 106: 565-569.
34. Bayley JP, de Rooij H, van den Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-alpha promoter. Cytokine 2001; 14: 316-323.
35. Nakao F, Ihara K, Kusuhara K et al. Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. J Allergy Clin Immunol 2001; 107: 499-504.
36. Cavet J, Dickinson AM, Norden J, Taylor PR, Jackson GH, Middleton PG. Interferon-gamma and interleukin-6 gene polymorphisms associate with graft-versus-host disease in HLA-matched sibling bone marrow transplantation. Blood 2001; 98: 1594-1600.
37. Nieters A, Brems S, Becker N. Cross-sectional study on cytokine polymorphisms, cytokine production after T-cell stimulation and clinical parameters in a random sample of a German population. Hum Genet 2001; 108: 241-248.
38. Jahromi M, Millward A, Demaine A. A CA repeat polymorphism of the IFN-gamma gene is associated with susceptibility to type 1 diabetes. J Interferon Cytokine Res 2000; 20: 187-190.
39. Dai Y, Masterman T, Huang WX et al. Analysis of an interferon-gamma gene dinucleotide-repeat polymorphism in Nordic multiple sclerosis patients. Mult Scler 2001; 7: 157-163.
40. Pelletier R, Pravica V, Perrey C et al. Evidence for a genetic predisposition towards acute rejection after kidney and simultaneous kidney-pancreas transplantation. Transplantation 2000; 70: 674-680.
41. Lee JY, Goldman D, Piliero LM, Petri M, Sullivan KE. Interferon-gamma polymorphisms in systemic lupus erythematosus. Genes Immun 2001; 2: 254-257.
42. Khani-Hanjani A, Lacaille D, Hoar D et al. Association between dinucleotide repeat in non-coding region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet 2000; 356: 820-825.
43. Pokorny V, McLean L, McQueen F, Abu-Maree M, Yeoman S. Interferon-gamma microsatellite and rheumatoid arthritis. Lancet 2001; 358: 122-123.
44. Takahashi H, Furukawa T, Hashimoto S et al. Contribution of TNF-alpha and IL-10 gene polymorphisms to graft-versus-host disease following allo-hematopoietic stem cell transplantation. Bone Marrow Transplant 2000; 26: 1317-1323.
45. Hennig BJ, Parkhill JM, Chapple IL, Heasman PA, Taylor JJ. Dinucleotide repeat polymorphism in the interleukin-10 gene promoter (IL-10.G) and genetic susceptibility to early-onset periodontal disease. Genes Immun 2000; 1: 402-404.
46. Asadullah K, Eskdale J, Wiese A, Gallagher G, Friedrich M, Sterry W. Interleukin-10 promoter polymorphism in psoriasis. J Invest Dermatol 2001; 116: 975-978.
47. Kaluza W, Leirisalo-Repo M, Marker-Hermann E et al. IL10.G microsatellites mark promoter haplotypes associated with protection against the development of reactive arthritis in Finnish patients. Arthritis Rheum 2001; 44: 1209-1214.
48. Bathgate AJ, Pravica V, Perrey C et al. The effect of polymorphisms in tumor necrosis factor-alpha, interleukin-10, and transforming growth factor-beta1 genes in acute hepatic allograft rejection. Transplantation 2000; 69: 1514-1517.
49. Bathgate AJ, Pravica V, Perrey C, Hayes PC, Hutchinson IV. Polymorphisms in tumour necrosis factor alpha, interleukin-10 and transforming growth factor beta1 genes and end-stage liver disease. Eur J Gastroenterol Hepatol 2000; 12: 1329-1333.
50. Maurer M, Kruse N, Giess R, Toyka KV, Rieckmann P. Genetic variation at position -1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis. J Neuroimmunol 2000; 104: 98-100.
51. Huizinga TW, Keijsers V, Yanni G et al. Are differences in interleukin 10 production associated with joint damage? Rheumatology (Oxford) 2000; 39: 1180-1188.
52. Tambur AR, Ortegel JW, Ben-Ari Z et al. Role of cytokine gene polymorphism in hepatitis c recurrence and allograft rejection among liver transplant recipients. Transplantation 2001; 71: 1475-1480.
53. Karhukorpi J, Laitinen T, Karttunen R, Tiilikainen AS. The functionally important IL-10 promoter polymorphism (-1082G→A) is not a major genetic regulator in recurrent spontaneous abortions. Mol Hum Reprod 2001; 7: 201-203.
54. Howell WM, Turner SJ, Bateman AC, Theaker JM. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma. Genes Immun 2001; 2: 25-31.
55. Marshall SE, McLaren AJ, Haldar NA, Bunce M, Morris PJ, Welsh KI. The impact of recipient cytokine genotype on acute rejection after renal transplantation. Transplantation 2000; 70: 1485-1491.
56. Poole KL, Gibbs PJ, Evans PR, Sadek SA, Howell WM. Influence of patient and donor cytokine genotypes on renal allograft rejection: evidence from a single centre study. Transpl Immunol 2001; 8: 259-265.
57. van der Linden MW, Westendorp RG, Sturk A, Bergman W, Huizinga TW. High interleukin-10 production in first-degree relatives of patients with generalized but not cutaneous lupus erythematosus. J Investig Med 2000; 48: 327-334.
58. Awad MR, Webber S, Boyle G et al. The effect of cytokine gene polymorphisms on pediatric heart allograft outcome. J Heart Lung Transplant 2001; 20: 625-630.
59. Klein W, Tromm A, Griga T et al. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis 2000; 21: 3578-3582.
60. Donaldson PT, Norris S, Constantini PK, Bernal W, Harrison P, Williams R. The interleukin-1 and interleukin-10 gene polymorphisms in primary sclerosing cholangitis: no associations with disease susceptibility/resistance. J Hepatol 2000; 32: 882-886.
61. Koch W, Kastrati A, Bottiger C, Mehilli J, von Beckerath N, Schomig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis 2001; 159: 137-144.
62. Helminen ME, Kilpinen S, Virta M, Hurme M. Susceptibility to primary Epstein-Barr virus infection is associated with interleukin-10 gene promoter polymorphism. J Infect Dis 2001; 184: 777-780.
63. Hulkkonen J, Pertovaara M, Antonen J, Lahdenpohja N, Pasternack A, Hurme M. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjogren's syndrome. Arthritis Rheum 2001; 44: 176-179.
64. Summers AM, Summers CW, Drucker DB, Hajeer AH, Barson A, Hutchinson IV. Association of IL-10 genotype with sudden infant death syndrome. Hum Immunol 2000; 61: 1270-1273.
65. Grove J, Daly AK, Bassendine MF, Gilvarry E, Day CP. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut 2000; 46: 540-545.
66. Mitchell SA, Grove J, Spurkland A et al. Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis. Gut 2001; 49: 288-294.
67. Aithal GP, Craggs A, Day CP et al. Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflamatory bowel disease. Dig Dis Sci 2001; 46: 1520-1525.
68. Leung TF, Tang NL, Chan IH, Li AM, Ha G, Lam CW. A polymorphism in the coding region of interleukin-13 gene is associated with atopy but not asthma in Chinese children. Clin Exp Allergy 2001; 31: 1515-1521.
69. Kristiansen OP, Pociot F, Johannesen J et al. Linkage disequilibrium testing of four interleukin-1 gene-cluster polymorphisms in Danish multiplex families with insulin-dependent diabetes mellitus. Cytokine 2000; 12: 171-175.
70. Schulte CM, Dignass AU, Goebell H, Roher HD, Schulte KM. Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterology 2000; 119: 909-920.
71. Iacoviello L, Donati MB, Gattone M. Possible different involvement of interleukin-1 receptor antagonist gene polymorphism in coronary single vessel disease and myocardial infarction. Circulation 2000; 101: E193.
72. Cullup H, Dickinson AM, Jackson GH, Taylor PR, Cavet J, Middleton PG. Donor interleukin 1 receptor antagonist genotype associated with acute graft-versus-host disease in human leucocyte antigen-matched sibling allogeneic transplants. Br J Haematol 2001; 113: 807-813.
73. Hamajima N, Matsuo K, Saito T et al. Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection. Jpn J Cancer Res 2001; 92: 383-389.
74. Feakes R, Sawcer S, Broadley S et al. Interleukin 1 receptor antagonist (IL-1ra) in multiple sclerosis. J Neuroimmunol 2000; 105: 96-101.
75. Bajnok E, Takacs I, Vargha P, Speer G, Nagy Z, Lakatos P. Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women. Bone 2000; 27: 559-562.
76. Son K, Tomita Y, Shimizu T, Nishinarita S, Sawada S, Horie T. Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis. Intern Med 2000; 39: 128-135.
77. Djouadi K, Nedelec B, Tamouza R et al. Interleukin 1 gene cluster polymorphisms in multiplex families with spondylarthropathies. Cytokine 2001; 13: 98-103.
78. Pastor IJ, Laso FJ, Avila JJ, Rodriguez RE, Gonzalez-Sarmiento R. Polymorphism in the interleukin-1 receptor antagonist gene is associated with alcoholism in Spanish men. Alcohol Clin Exp Res 2000; 24: 1479-1482.
79. Rider LG, Artlett CM, Foster CB et al. Polymorphisms in the IL-1 receptor antagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies. Clin Exp Immunol 2000; 121: 47-52.
80. Arkwright PD, Chase JM, Babbage S, Pravica V, David TJ, Hutchinson IV. Atopic dermatitis is associated with a low-producer transforming growth factor beta(1) cytokine genotype. J Allergy Clin Immunol 2001; 108: 281-284.
81. McKibbin M, Clark B, Lee H, Isaacs JD, Gooi HC, Morrell AJ. No strong association between alleles of tumour necrosis factor alpha and interleukin-1 receptor antagonist and corneal melting associated with systemic vasculitis. Br J Ophthalmol 2000; 84: 395-398.
82. Zheng C, Huang DR, Bergenbrant S et al. Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Haematol 2000; 109: 39-45.
83. Langdahl BL, Lokke E, Carstens M, Stenkjaer LL, Eriksen EF. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1 - receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene. J Bone Miner Res 2000; 15: 402-414.
84. Witkin SS, Linhares IM, Gerber S, Caetano ME, Segurado AC. Interleukin-1 receptor antagonist gene polymorphism and circulating levels of human immunodeficiency virus type 1 RNA in BraziIian women. J Virol 2001; 75: 6242-6244.
85. Ishii T, Matsuse T, Teramoto S et al. Neither IL-1beta, IL-1 receptor antagonist, nor TNF-alpha polymorphisms are associated with susceptibility to COPD. Respir Med 2000; 94: 847-851.
86. Rebeck GW. Confirmation of the genetic association of interleukin-1A with early onset sporadic Alzheimer's disease. Neurosci Lett 2000; 293: 75-77.
87. Machado JC, Pharoah P, Sousa S et al. Interleukin 1b and interleukin 1rn polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121: 823-829.
88. El-Omar EM. The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 2001; 48: 743-747.
89. Tempfer C, Unfried G, Lessl K, Nagele F, Huber JC. Interleukin-1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Obstet Gynecol 2001; 97: S31.
90. Unfried G, Tempfer C, Schneeberger C, Widmar B, Nagele F, Huber JC. Interleukin 1 receptor antagonist polymorphism in women with idiopathic recurrent miscarriage. Fertil Steril 2001; 75: 683-687.
91. Shu KH, Lee SH, Cheng CH, Wu MJ, Lian JD. Impact of interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism on IgA nephropathy. Kidney Int 2000; 58: 783-789.
92. Vencovsky J, Jarosova K, Ruzickova S et al. Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis. Arthritis Rheum 2001; 44: 2387-2391.
93. Makela S, Hurme M, Ala-Houhala I et al. Polymorphism of the cytokine genes in hospitalized patients with Puumala hanta-virus infection. Nephrol Dial Transplant 2001; 16: 1368-1373.
94. Francis SE, Camp NJ, Burton AJ et al. Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty. Heart 2001; 86: 336-340.
95. Jeremias J, Ledger WJ, Witkin SS. Interleukin 1 receptor antagonist gene polymorphism in women with vulvar vestibulitis. Am J Obstet Gynecol 2000; 182: 283-285.
96. Joos L, McIntyre L, Ruan J et al. Association of IL-1beta and IL-1 receptor antagonist haplotypes with rate of decline in lung function in smokers. Thorax 2001; 56: 863-866.
97. Parkhill JM, Hennig BJ, Chapple IL, Heasman PA, Taylor JJ. Association of interleukin-1 gene polymorphisms with early-onset periodontitis. J Clin Periodontol 2000; 27: 682-689.
98. Whyte M, Hubbard R, Meliconi R et al. Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor-alpha gene polymorphisms. Am J Respir Crit Care Med 2000; 162: 755-758.
99. Carter MJ, Di Giovine FS, Cox A et al. The interleukin 1 receptor antagonist gene allele 2 as a predictor of pouchitis following colectomy and ipaa in ulcerative colitis. Gastroenterology 2001; 121: 805-811.
100. Kastrati A, Koch W, Berger PB et al. Protective role against restenosis from an interleukin-1 receptor antagonist gene polymorphism in patients treated with coronary stenting. J Am Coll Cardiol 2000; 36: 2168-2173.
101. Du Y, Dodel RC, Eastwood BJ et al. Association of an interleukin 1 alpha polymorphism with Alzheimer's disease. Neurology 2000; 55: 480-483.
102. Grimaldi LM, Casadei VM, Ferri C et al. Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol 2000; 47: 361-365.
103. Ferri C, Sciacca FL, Grimaldi LE et al. Lack of association between IL-1A and IL-1B promoter polymorphisms and multiple sclerosis. J Neurol Neurosurg Psychiatry 2000; 69: 564-565.
104. Shirodaria S, Smith J, McKay IJ, Kennett CN, Hughes FJ. Polymorphisms in the IL-1A gene are correlated with levels of interleukin-1alpha protein in gingival crevicular fluid of teeth with severe periodontal disease. J Dent Res 2000; 79: 1864-1869.
105. Nicoll JA, Mrak RE, Graham DI et al. Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 2000; 47: 365-368.
106. McDevitt MJ, Wang HY, Knobelman C et al. Interleukin-1 genetic association with periodontitis in clinical practice. J Periodontol 2000; 71: 156-163.
107. Papapanou PN, Neiderud AM, Sandros J, Dahlen G. Interleukin-1 gene polymorphism and periodontal status. A case-control study. J Clin Periodontol 2001; 28: 389-396.
108. Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG. Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis. J Neuroimmunol 2000; 106: 220-227.
109. Licastro F, Pedrini S, Ferri C et al. Gene polymorphism affecting alpha1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann Neurol 2000; 48: 388-391.
110. Mwantembe O, Gaillard MC, Barkhuizen M et al. Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease (IBD) and in control individuals. Immunogenetics 2001; 52: 249-254.
111. Barber MD, Powell JJ, Lynch SF, Fearon KC, Ross JA. A polymorphism of the interleukin-1 beta gene influences survival in pancreatic cancer. Br J Cancer 2000; 83: 1443-1447.
112. Boiardi L, Salvarani C, Timms JM, Silvestri T, Macchioni PL, di Giovine FS. Interleukin-1 cluster and tumor necrosis factor-alpha gene polymorphisms in polymyalgia rheumatica. Clin Exp Rheumatol 2000; 18: 675-681.
113. Yucesoy B, Vallyathan V, Landsittel DP et al. Polymorphisms of the IL-1 gene complex in coal miners with silicosis. Am J Ind Med 2001; 39: 286-291.
114. Hefler LA, Tempfer CB, Unfried G et al. A polymorphism of the interleukin-1beta gene and idiopathic recurrent miscarriage. Fertil Steril 2001; 76: 377-379.
115. Buchs N, di Giovine FS, Silvestri T, Vannier E, Duff GW, Miossec P. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun 2001; 2: 222-228.
116. Walker SJ, Van Dyke TE, Rich S, Kornman KS, di Giovine FS, Hart TC. Genetic polymorphisms of the IL-1alpha and IL-1beta genes in African-American LJP patients and an African-American control population. J Periodontol 2000; 71: 723-728.
117. Garcia-Gonzalez MA, Lanas A, Santolaria S, Crusius JB, Serrano MT, Pena AS. The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer. Clin Exp Immunol 2001; 125: 368-375.
118. Armitage GC, Wu Y, Wang HY, Sorrell J, di Giovine FS, Duff GW. Low prevalence of a periodontitis-associated interleukin-1 composite genotype in individuals of Chinese heritage. J Periodontol 2000; 71: 164-171.
119. Socransky SS, Haffajee AD, Smith C, Duff GW. Microbiological parameters associated with IL-1 gene polymorphisms in periodontitis patients. J Clin Periodontol 2000; 27: 810-818.
120. Huang D, Giscombe R, Zhou Y, Lefvert AK. Polymorphisms in CTLA-4 but not tumor necrosis factor-alpha or interleukin 1beta genes are associated with Wegener's granulomatosis. J Rheumatol 2000; 27: 397-401.
121. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura N. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol 2001; 36: 696-699.
122. Buono RJ, Ferraro TN, O'Connor MJ et al. Lack of association between an interleukin 1 beta (IL-1beta) gene variation and refractory temporal lobe epilepsy. Epilepsia 2001; 42: 782-784.
123. Meisenzahl EM, Rujescu D, Kirner A et al. Association of an interleukin-1beta genetic polymorphism with altered brain structure in patients with schizophrenia. Am J Psychiatry 2001; 158: 1316-1319.
124. Nishimura M, Mizuta I, Mizuta E, Yamasaki S, Ohta M, Kuno S. Influence of interleukin-1beta gene polymorphisms on age-at-onset of sporadic Parkinson's disease. Neurosci Lett 2000; 284: 73-76.
125. Kanemoto K, Kawasaki J, Miyamoto T, Obayashi H, Nishimura M. Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann Neurol 2000; 47: 571-574.
126. Peltola J, Keranen T, Rainesalo S, Hurme M. Polymorphism of the interleukin-1 gene complex in localization-related epilepsy. Ann Neurol 2001; 50: 275-276.
127. Read RC, Camp NJ, di Giovine FS et al. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis 2000; 182: 1557-1560.
128. Nishimura M, Kawakami H, Maruyama H et al. Influence of interleukin-1beta gene polymorphism on age-at-onset of spino-cerebellar ataxia 6 (SCA6) in Japanese patients. Neurosci Lett 2001; 307: 128-130.
129. Takamatsu M, Yamauchi M, Maezawa Y, Saito S, Maeyama S, Uchikoshi T. Genetic polymorphisms of interleukin-1beta in association with the development of alcoholic liver disease in Japanese patients. Am J Gastroenterol 2000; 95: 1305-1311.
130. Luomala M, Lehtimaki T, Elovaara I et al. A study of interleukin-1 cluster genes in susceptibility to and severity of multiple sclerosis. J Neurol Sci 2001; 185: 123-127.
131. Yamada R, Tanaka T, Unoki M et al. Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibility to the disease. Am J Hum Genet 2001; 68: 674-685.
132. Elliott K, Fitzpatrick E, Hill D et al. The -590C/T and -34C/T interleukin-4 promoter polymorphisms are not associated with atopic eczema in childhood. J Allergy Clin Immunol 2001; 108: 285-287.
133. Hunt PJ, Marshall SE, Weetman AP, Bell JI, Wass JA, Welsh KI. Cytokine gene polymorphisms in autoimmune thyroid disease. J Clin Endocrinol Metab 2000; 85: 1984-1988.
134. Cartwright NH, Keen LJ, Demaine AG et al. A study of cytokine gene polymorphisms and protein secretion in renal transplantation. Transpl Immunol 2001; 8: 237-244.
135. Nakayama EE, Hoshino Y, Xin X et al. Polymorphism in the interleukin-4 promoter affects acquisition of human immunodeficiency virus type 1 syncytium-inducing phenotype. J Virol 2000; 74: 5452-5459.
136. Hijazi Z, Haider MZ. Interleukin-4 gene promoter polymorphism [C590T] and asthma in Kuwaiti Arabs. Int Arch Allergy Immunol 2000; 122: 190-194.
137. Sandford AJ, Chagani T, Zhu S et al. Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. J Allergy Clin Immunol 2000; 106: 135-140.
138. Zhu S, Chan-Yeung M, Becker AB et al. Polymorphisms of the IL-4, TNF-alpha, and Fcepsilon RIbeta genes and the risk of allergic disorders in at-risk infants. Am J Respir Crit Care Med 2000; 161: 1655-1659.
139. Takabayashi A, Ihara K, Sasaki Y et al. Childhood atopic asthma: positive association with a polymorphism of IL-4 receptor alpha gene but not with that of IL-4 promoter or Fc epsilon receptor I beta gene. Exp Clin Immunogenet 2000; 17: 63-70.
140. Klein W, Tromm A, Griga T et al. Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases. Genes Immun 2001; 2: 287-289.
141. Buchs N, SiIvestri T, di Giovine FS et al. IL-4 VNTR gene polymorphism in chronic polyarthritis. The rare allele is associated with protection against destruction. Rheumatology (Oxf) 2000; 39: 1126-1131.
142. Olavesen MG, Hampe J, Mirza MM et al. Analysis of single-nucleotide polymorphisms in the interleukin-4 receptor gene for association with inflammatory bowel disease. Immunogenetics 2000; 51: 1-7.
143. Aithal GP, Day CP, Leathart J, Daly AK, Hudson M. Association of single nucleotide polymorphisms in the interleukin-4 gene and interleukin-4 receptor gene with Crohn's disease in a British population. Genes Immun 2001; 2: 44-47.
144. Oiso N, Fukai K, Ishii M. Interleukin 4 receptor alpha chain polymorphism Gln551Arg is associated with adult atopic dermatitis in Japan. Br J Dermatol 2000; 142: 1003-1006.
145. Daley T, Metcalfe DD, Akin C. Association of the Q576R polymorphism in the interleukin-4 receptor alpha chain with indolent mastocytosis limited to the skin. Blood 2001; 98: 880-882.
146. Andrews RP, Burrell L, Rosa-Rosa L et al. Analysis of the Ser78-6Pro interleukin-4 receptor alpha allelic variant in allergic and nonallergic asthma and its functional consequences. Clin Immunol 2001; 100: 298-304.
147. Pantelidis P, Fanning GC, Wells AU, Welsh KI, Du Bois RM. Analysis of tumor necrosis factor-alpha, lymphotoxin-alpha, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001; 163: 1432-1436.
148. Jones KG, Brull DJ, Brown LC et al. Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 2001.; 103: 2260-2265.
149. Bagli M, Papassotiropoulos A, Knapp M et al. Association between an interleukin-6 promoter and 3-pm flanking region haplotype and reduced Alzheimer's disease risk in a German population. Neurosci Lett 2000; 283: 109-112.
150. Collado-Escobar MD, Nieto A, Mataran L, Raya E, Martin J. Interleukin 6 gene promoter polymorphism is not associated with ankylosing spondylitis. J Rheumatol 2000; 27: 1461-1463.
151. Rauramaa R, Vaisanen SB, Luong LA et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 2000; 20: 2657-2662.
152. Klein W, Tromm A, Griga T et al. The polymorphism at position -174 of the IL-6 gene is not associated with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2001; 13: 45-47.
153. Jahromi MM, Millward BA, Demaine AG. A polymorphism in the promoter region of the gene for interleukin-6 is associated with susceptibility to type 1 diabetes mellitus. J Interferon Cytokine Res 2000; 20: 885-888.
154. Foster CB, Lehrnbecher T, Samuels S et al. An IL6 promoter polymorphism is associated with a lifetime risk of development of Kaposi sarcoma in men infected with human immunodeficiency virus. Blood 2000; 96: 2562-2567.
155. Fernandez-Real JM, Broch M, Vendrell J, Richart C, Ricart W. Interleukin-6 gene polymorphism and lipid abnormalities in healthy subjects. J Clin Endocrinol Metab 2000; 85: 1334-1339.
156. Ferrari SL, Garnero P, Emond S, Montgomery H, Humphries SE, Greenspan SL. A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. Arthritis Rheum 2001; 44: 196-201.
157. Hulkkonen J, Pertovaara M, Antonen J, Pasternack A, Hurme M. Elevated interleukin-6 plasma levels are regulated by the promoter region polymorphism of the IL6 gene in primary Sjogren's syndrome and correlate with the clinical manifestations of the disease. Rheumatology (Oxf) 2001; 40: 656-661.
158. Reviron D, Dussol B, Andre M, Brunet P, Mercier P, Berland Y. TNF-alpha and IL-6 gene polymorphism and rejection in kidney transplantation recipients. Transplant Proc 2001; 33: 350-351.
159. Marshall SE, McLaren AJ, McKinney EF et al. Donor cytokine genotype influences the development of acute rejection after renal transplantation. Transplantation 2001; 71: 469-476.
160. Schotte H, Schluter B, Rust S, Assmann G, Domschke W, Gaubitz M. Interleukin-6 promoter polymorphism (-174 G/C) in Caucasian German patients with systemic lupus erythematosus. Rheumatology (Oxf) 2001; 40: 393-400.
161. Fedetz M, Matesanz F, Pascual M et al. The -174/-597 promoter polymorphisms in the interleukin-6 gene are not associated with susceptibility to multiple sclerosis. J Neurol Sci 2001; 190: 69-72.
162. Pascual M, Nieto A, Mataran L, Balsa A, Pascual-Salcedo D, Martin J. IL-6 promoter polymorphisms in rheumatoid arthritis. Genes Immun 2000; 1: 338-340.
163. Vandenbroeck K, Fiten P, Ronsse I et al. High-resolution analysis of IL-6 minisatellite polymorphism in Sardinian multiple sclerosis: effect on course and onset of disease. Genes Immun 2000; 1: 460-463.
164. Schmidt S, Papassotiropoulos A, Bagli M, Harzheim M, Heun R, Klockgether T. No association of serum levels of interleukin-6 and its soluble receptor components with a genetic variation in the 3′ flanking region of the interleukin-6 gene in patients with multiple sclerosis. Neurosci Lett 2000; 294: 139-142.
165. Takacs I, Koller DL, Peacock M et al. Sib pair linkage and association studies between bone mineral density and the interleukin-6 gene locus. Bone 2000; 27: 169-173.
166. Castro J, Telleria JJ, Linares P, Blanco-Quiros A. Increased TNFA*2, but not TNFB*1, allele frequency in Spanish atopic patients. J Investig Allergol Clin Immunol 2000; 10: 149-154.
167. Weitkamp JH, Stuber F, Bartmann P. Pilot study assessing TNF gene polymorphism as a prognostic marker for disease progression in neonates with sepsis. Infection 2000; 28: 92-96.
168. Hayakawa T, Nagai Y, Taniguchi M et al. Tumor necrosis factor-beta gene NcoI polymorphism decreases insulin resistance in Japanese men. Metabolism 2000; 49: 1506-1509.
169. Kankova K, Muzik J, Karaskova J et al. Duration of non-Insulin-dependent diabetes mellitus and the TNF-beta NcoI genotype as predictive factors in proliferative diabetic retinopathy. Ophthalmologica 2001; 215: 294-298.
170. Waterer GW, Quasney MW, Cantor RM, Wunderink RG. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med 2001; 163: 1599-1604.
171. Yamauchi M, Takamatsu M, Maezawa Y et al. Polymorphism of tumor necrosis factor-beta and alcohol dehydrogenase genes and alcoholic brain atrophy in japanese patients. Alcohol Clin Exp Res 2001; 25: 7S-10S.
172. Yamaguchi E, Itoh A, Hizawa N, Kawakami Y. The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis. Chest 2001; 119: 753-761.
173. Foster CB, Zhu S, Erichsen HC et al. Polymorphisms in inflammatory cytokines and Fcgamma receptors in childhood chronic immune thrombocytopenic purpura: a pilot study. Br J Haematol 2001; 113: 596-599.
174. Vasku V, Vasku A, Izakovicova Holla L et al. Polymorphisms in inflammation genes (angiotensinogen, TAP1 and TNF-beta) in psoriasis. Arch Dermatol Res 2000; 292: 531-534.
175. Fryer AA, Spiteri MA, Bianco A et al. The -403 G→A promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes Immun 2000; 1: 509-514.
176. Marshall H. RANTES polymorphism affects susceptibility to HIV and asthma. Trends Immunol 2001; 22: 13.
177. McDermott DH, Beecroft MJ, Kleeberger CA et al. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. Aids 2000; 14: 2671-2678.
178. Tanabe A, Taketani S, Endo-Ichikawa Y, Tokunaga R, Ogawa Y, Hiramoto M. Analysis of the candidate genes responsible for non-syndromic cleft lip and palate in Japanese people. Clin Sci (Lond) 2000; 99: 105-111.
179. Green AJ, Barcellos LF, Rimmler JB et al. Sequence variation in the transforming growth factor-beta1 (TGFB1) gene and multiple sclerosis susceptibility. J Neuroimmunol 2001; 116: 116-124.
180. Zhou X, Tan FK, Stivers DN, Arnett FC. Microsatellites and intragenic polymorphisms of transforming growth factor beta and platelet-derived growth factor and their receptor genes in Native Americans with systemic sclerosis (scleroderma): a preliminary analysis showing no genetic association. Arthritis Rheum 2000; 43: 1068-1073.
181. Yamada Y, Miyauchi A, Takagi Y, Tanaka M, Mizuno M, Harada A. Association of the C-509→,T polymorphism, alone of in combination with the T869→,C polymorphism, of the transforming growth factor-beta1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women. J Mol Med 2001; 79: 149-156.
182. Bertoldo F, D'Agruma L, Furlan F et al. Transforming growth factor-beta1 gene polymorphism, bone turnover, and bone mass in Italian postmenopausal women. J Bone Miner Res 2000; 15: 634-639.
183. Perrotta S, Cappellini MD, Bertoldo F et al. Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background. Br J Haematol 2000; 111: 461-466.
184. Ziv E, Cauley J, Morin PA, Saiz R, Browner WS. Association between the T29→C polymorphism in the transforming growth factor beta1 gene and breast cancer among elderly white women: The Study of Osteoporotic Fractures. JAMA 2001; 285: 2859-2863.
185. Holgate ST, Lackie PM, Howarth PH et al. Invited lecture: activation of the epithelial mesenchymal trophic unit in the pathogenesis of asthma. Int Arch Allergy Immunol 2001; 124: 253-258.
186. Holweg CT, Baan CC, Balk AH et al. The transforming growth factor-beta1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation 2001; 71: 1463-1467.
187. Yokota M, Ichihara S, Lin TL, Nakashima N, Yamada Y. Association of a T29→,C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. Circulation 2000; 101: 2783-2787.
188. Kamiya M, Harada A, Mizuno M, Iwata H, Yamada Y. Association between a polymorphism of the transforming growth factor-beta1 gene and genetic susceptibility to ossification of the posterior longitudinal ligament in japanese patients. Spine 2001; 26: 1264-1267.
189. Yamada Y. Association of a Leu(10)→Pro polymorphism of the transforming growth factor-beta1 with genetic susceptibility to osteoporosis and spinal osteoarthritis. Mech Ageing Dev 2000; 116: 113-123.
190. Akai Y, Sato H, Ozaki H, Iwano M, Dohi Y, Kanauchi M. Association of transforming growth factor-beta1 T29C polymorphism with the progression of diabetic nephropathy. Am J Kidney Dis 2001; 38: S182-S185.
191. Yamada Y, Okuizumi H, Miyauchi A, Takagi Y, Ikeda K, Harada A. Association of transforming growth factor beta1 genotype with spinal osteophytosis in Japanese women. Arthritis Rheum 2000; 43: 452-460.
192. Tiret L, Mallet C, Poirier O et al. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol 2000; 35: 29-35.
193. Baan CC, Balk AH, Holweg CT et al. Renal failure after clinical heart transplantation is associated with the TGF-beta 1 codon 10 gene polymorphism. J Heart Lung Transplant 2000; 19: 866-872.
194. Densem CG, Hutchinson IV, Cooper A, Yonan N, Brooks NH. Polymorphism of the transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation. J Heart Lung Transplant 2000; 19: 551-556.
195. Chen T, Triplett J, Dehner B et al. Transforming growth factor-beta receptor type i gene is frequently mutated in ovarian carcinomas. Cancer Res 2001; 61: 4679-4682.
196. Wang D, Kanuma T, Mizunuma H et al. Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer. Cancer Res 2000; 60: 4507-4512.
197. Shin KH, Park YJ, Park JG. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients. Clin Cancer Res 2000; 6: 536-540.
198. Hajeer AH, Lear JT, Ollier WE et al. Preliminary evidence of an association of tumour necrosis factor microsatellites with increased risk of multiple basal cell carcinomas. Br J Dermatol 2000; 142: 441-445.
199. Martinez A, Fernandez-Arquero M, Pascual-Salcedo D et al. Primary association of tumor necrosis factor-region genetic markers with susceptibility to rheumatoid arthritis. Arthritis Rheum 2000; 43: 1366-1370.
200. De la Concha EG, Fernandez-Arquero M, Vigil P et al. Tumor necrosis factor genomic polymorphism in Spanish IGA deficiency patients. Tissue Antigens 2000; 55: 359-363.
201. Ghaderi M, Nikitina Zake L, Wallin K et al. Tumor necrosis factor A and MHC class I chain related gene A (MIC-A) polymorphisms in Swedish patients with cervical cancer. Hum Immunol 2001; 62: 1153-1158.
202. Ghaderi M, Nikitina L, Peacock CS et al. Tumor necrosis factor a-11 and DR15-DQ6 (B*0602) haplotype increase the risk for cervical intraepithelial neoplasia in human papillomavirus 16 seropositive women in Northern Sweden. Cancer Epidemiol Biomarkers Prev 2000; 9: 1067-1070.
203. Lucotte G, Bathelier C, Mercier G. TNF-alpha polymorphisms in multiple sclerosis: no association with -238 and -308 promoter alleles, but the microsatellite allele a11 is associated with the disease in French patients. Mult Scler 2000; 6: 78-80.
204. Kumaramanickavel G, Sripriya S, Vellanki RN et al. Tumor necrosis factor allelic polymorphism with diabetic retinopathy in India. Diabetes Res Clin Pract 2001; 54: 89-94.
205. Obayashi H, Hasegawa G, Fukui M et al. Tumor necrosis factor microsatellite polymorphism influences the development of insulin dependency in adult-onset diabetes patients with the DRB1*1502-DQB1*0601 allele and anti-glutamic acid decarboxylase antibodies. J Clin Endocrinol Metab 2000; 85: 3348-3351.
206. Takeuchi F, Nabeta H, Fussel M, Conrad K, Frank KH. Association of the TNFa13 microsatellite with systemic sclerosis in Japanese patients. Ann Rheum Dis 2000; 59: 293-296.
207. Perry RT, Collins JS, Harrell LE, Acton RT, Go RC. Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am J Med Genet 2001; 105: 332-342.
208. Mattey DL, Hajeer AH, Dababneh A et al. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Arthritis Rheum 2000; 43: 1749-1755.
209. Saito S, Kasai Y, Nomoto S, Fujiwara M, Akiyama S, Ito K, Nakao A. Polymorphism of tumor necrosis factor in esophageal, gastric or colorectal carcinoma. Hepatogastroenterology 2001; 48: 468-470.
210. Castro F, Acevedo E, Ciusani E, Angulo JA, Wollheim FA, Sandberg-Wollheim M. Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis. Ann Rheum Dis 2001; 60: 791-795.
211. Boiko AN, Guseva ME, Guseva MR et al. Clinico-immunogenetic characteristics of multiple sclerosis with optic neuritis in children. J Neurovirol 2000; 6: S152-S155.
212. Kruger R, Hardt C, Tschentscher F et al. Genetic analysis of immunomodulating factors in sporadic Parkinson's disease. J Neural Transm 2000; 107: 553-562.
213. Wassink TH, Crowe RR, Andreasen NC. Tumor necrosis factor receptor-II: heritability and effect on brain morphology in schizophrenia. Mol Psychiatry 2000; 5: 678-682.
214. Sullivan KE, Piliero LM, Goldman D, Petri MA. A TNFR2 3′ flanking region polymorphism in systemic lupus erythematosus. Genes Immun 2000; 1: 225-227.
215. Takahashi M, Hashimoto H, Akizuki M et al. Lack of association between the Met196Arg polymorphism in the TNFR2 gene and autoimmune diseases accompanied by vasculitis including SLE in Japanese. Tissue Antigens 2001; 57: 66-69.
216. Kawasaki A, Tsuchiya N, Hagiwara K, Takazoe M, Tokunaga K. Independent contribution of HLA-DRB1 and TNF alpha promoter polymorphisms to the susceptibility to Crohn's disease. Genes Immun 2000; 1: 351-357.
217. Hohjoh H, Terada N, Kawashima M, Honda Y, Tokunaga K. Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy. Tissue Antigens 2000; 56: 446-448.
218. Barton A, John S, Ollier WE, Silman A, Worthington J. Association between rheumatoid arthritis and polymorphism of tumor necrosis factor receptor II, but not tumor necrosis factor receptor I, in Caucasians. Arthritis Rheum 2001; 44: 61-65.
219. Shibue T, Tsuchiya N, Komata T et al. Tumor necrosis factor alpha 5′-flanking region, tumor necrosis factor receptor II, and HLA-DRB1 polymorphisms in Japanese patients with rheumatoid arthritis. Arthritis Rheum 2000; 43: 753-757.
220. Al-Ansari AS, Ollier WE, Villarreal J, Ordi J, Teh LS, Hajeer AH. Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus. Tissue Antigens 2000; 55: 97-99.
221. Lee EB, Yoo JE, Lee YJ, Choi YJ, Park KS, Song YW. Tumor necrosis factor receptor 2 polymorphism in systemic lupus erythematosus: no association with disease. Hum Immunol 2001; 62: 1148-1152.
222. Hananantachai H, Patarapotikul J, Looareesuwan S, Ohashi J, Naka I, Tokunaga K. Lack of association of -308A/G TNFA promoter and 196R/M TNFR2 polymorphisms with disease severity in Thai adult malaria patients. Am J Med Genet 2001; 102: 391-392.
223. Geurts JM, Janssen RG, van Greevenbroek MM et al. Identification of TNFRSF1B as a novel modifier gene in familial combined hyperlipidemia. Hum Mol Genet 2000; 9: 2067-2074.
224. Benjafield AV, Wang XL, Morris BJ. Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease. J Mol Med 2001; 79: 109-115.
225. Tsuchiya N, Komata T, Matsushita M, Ohashi J, Tokunaga K. New single nucleotide polymorphisms in the coding region of human TNFR2: association with systemic lupus erythematosus. Genes Immun 2000; 1: 501-503.
226. Kamizono S, Hiromatsu Y, Seki N et al. A polymorphism of the 5′ flanking region of tumour necrosis factor alpha gene is associated with thyroid-associated ophthalmopathy in Japanese. Clin Endocrinol (Oxf) 2000; 52: 759-764.
227. Nishimura M, Mizuta I, Mizuta E et al. Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease. Neurosci Lett 2001; 311: 1-4.
228. Nishimura M, Maeda M, Matsuoka M et al. Tumor necrosis factor, tumor necrosis factor receptors type 1 and 2, lymphotoxin-alpha, and HLA-DRB1 gene polymorphisms in human T-cell lymphotropic virus type I associated myelopathy. Hum Immunol 2000; 61: 1262-1269.
229. Hamamoto Y, Tateno H, Ishida T, Muto M. Lack of association between promoter polymorphism of the tumor necrosis factor-alpha gene and psoriatic arthritis in Japanese patients. J Invest Dermatol 2000; 115: 1162-1164.
230. Milicic A, Lindheimer F, Laval S et al. Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis. Genes Immun 2000; 1: 418-422.
231. Gonzalez S, Torre-Alonso JC, Martinez-Borra J et al. TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients. J Rheumatol 2001; 28: 1288-1293.
232. Bertolaccini ML, Atsumi T, Lanchbury JS et al. Plasma tumor necrosis factor alpha levels and the -238*A promoter polymorphism in patients with antiphospholipid syndrome. Thromb Haemost 2001; 85: 198-203.
233. Caballero A, Bravo MJ, Nieto A, Colmenero JD, Alonso A, Martin J. TNFA promoter polymorphism and susceptibility to brucellosis. Clin Exp Immunol 2000; 121: 480-483.
234. Jang WH, Yang YI, Yea SS et al. The -238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 2001; 166: 41-46.
235. Rasmussen SK, Urhammer SA, Jensen JN, Hansen T, Borch-Johnsen K, Pedersen O. The -238 and -308 G→,A polymorphisms of the tumor necrosis factor alpha gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. J Clin Endocrinol Metab 2000; 85: 1731-1734.
236. Pirmohamed M, Lin K, Chadwick D, Park BK. TNFalpha promoter region gene polymorphisms in carbamazepine-hyper-sensitive patients. Neurology 2001; 56: 890-896.
237. Yee LJ, Tang J, Herrera J, Kaslow RA, van Leeuwen DJ. Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection. Genes Immun 2000; 1: 386-390.
238. Anlar B, Alikasifoglu M, Kose G, Guven A, Gurer Y, Yakut A. Tumor necrosis factor-alpha gene polymorphisms in children with multiple sclerosis. Neuropediatrics 2001; 32: 214-216.
239. Louis R, Leyder E, Malaise M, Bartsch P, Louis E. Lack of association between adult asthma and the tumour necrosis factor alpha-308 polymorphism gene. Eur Respir J 2000; 16: 604-608.
240. Thomas PS. Tumour necrosis factor-alpha: The role of this multifunctional cytokine in asthma. Immunol Cell Biol 2001; 79: 132-140.
241. Keso T, Perola M, Laippala P et al. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis 2001; 154: 691-697.
242. Wang XL, Oosterhof J. Tumour necrosis factor alpha G-308→,A polymorphism and risk for coronary artery disease. Clin Sci (Lond) 2000; 98: 435-437.
243. Middle F, Jones I, Robertson E, Lendon C, Craddock N. Tumour necrosis factor alpha and bipolar affective puerperal psychosis. Psychiatr Genet 2000; 10: 195-198.
244. de la Concha EG, Fernandez-Arquero M, Vigil P et al. Celiac disease and TNF promoter polymorphisms. Hum Immunol 2000; 61: 513-517.
245. Higham MA, Pride NB, Alikhan A, Morrell NW. Tumour necrosis factor-alpha gene promoter polymorphism in chronic obstructive pulmonary disease. Eur Respir J 2000; 15: 281-284.
246. Keatings VM, Cave SJ, Henry MJ et al. A polymorphism in the tumor necrosis factor-alpha gene promoter region may predispose to a poor prognosis in COPD. Chest 2000; 118: 971-975.
247. Lee SC, Pu YB, Thomas GN et al. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Metabolism 2000; 49: 1021-1024.
248. da Sliva B, Gapstur SM, Achenbach YH et al. Lack of association between the -308 polymorphism of the tumor necrosis factor-alpha gene and the insulin resistance syndrome. J Investig Med 2000; 48: 236-244.
249. Allen MH, Wakelin SH, Holloway D et al. Association of TNFA gene polymorphism at position -308 with susceptibility to irritant contact dermatitis. Immunogenetics 2000; 51: 201-205.
250. Fargion S, Valenti L, Dongiovanni P et al. Tumor necrosis factor alpha promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis. Blood 2001; 97: 3707-3712.
251. Lacki JK, Moser R, Korczowska I, Mackiewicz S, Muller W. TNF-alpha gene polymorphism does not affect the clinical and radiological outcome of rheumatoid arthritis. Rheumatol Int 2000; 19: 137-140.
252. Boin F, Zanardini R, Pioli R, Altamura CA, Maes M, Gennarelli M. Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiatry 2001; 6: 79-82.
253. Werth VP, Zhang W, Dortzbach K, Sullivan K. Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription. J Invest Dermatol 2000; 115: 726-730.
254. Padovani JC, Pazin-Filho A, Simoes MV, Marin-Neto JA, Zago MA, Franco RF. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res 2000; 100: 263-269.
255. Shaw MA, Donaldson IJ, Collins A et al. Association and linkage of leprosy phenotypes with HLA class II and tumour necrosis factor genes. Genes Immun 2001; 2: 196-204.
256. Sakao S, Tatsumi K, Igari H, Shino Y, Shirasawa H, Kuriyama T. Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 420-422.
257. Teramoto S, Ishii T. No association of tumor necrosis factor-alpha gene polymorphism and copd in Caucasian smokers and Japanese smokers. Chest 2001; 119: 315-316.
258. Schaaf BM, Seitzer U, Pravica V, Aries SP, Zabel P. Tumor necrosis factor-alpha -308 promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer's lung patients. Am J Respir Crit Care Med 2001; 163: 379-382.
259. Rudwaleit M, Siegert S, Yin Z et al. Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 2001; 60: 36-42.
260. Patio-Garcia A, Sotillo-Pieiro E, Modesto C, Sierrases-Maga L. Analysis of the human tumour necrosis factor-alpha (TNFalpha) gene promoter polymorphisms in children with bone cancer. J Med Genet 2000; 37: 789-792.
261. Mestiri S, Bouaouina N, Ahmed SB et al. Genetic variation in the tumor necrosis factor-alpha promoter region and in the stress protein hsp70-2: susceptibility and prognostic implications in breast carcinoma. Cancer 2001; 91: 672-678.
262. Winchester EC, Millwood IY, Rand L, Penny MA, Kessling AM. Association of the TNF-alpha-308 (G→A) polymorphism with self-reported history of childhood asthma. Hum Genet 2000; 107: 591-596.
263. Maier LA, Sawyer RT, Bauer RA et al. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease. Am J Respir Crit Care Med 2001; 164: 1192-1199.
264. Moraes MO, Duppre NC, Suffys PN et al. Tumor necrosis factor-alpha promoter polymorphism TNF2 is associated with a stronger delayed-type hypersensitivity reaction in the skin of borderline tuberculoid leprosy patients. Immunogenetics 2001; 53: 45-47.
265. Labunski S, Posern G, Ludwig S, Kundt G, Brocker EB, Kunz M. Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum. Acta Derm Venereol 2001; 81: 18-21.
266. Yea SS, Yang YI, Jang WH, Lee YJ, Bae HS, Paik KH. Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection. J Clin Pathol 2001; 54: 703-706.
267. Santos AR, Almeida AS, Suffys PN et al. Tumor necrosis factor promoter polymorphism (TNF2) seems to protect against development of severe forms of leprosy in a pilot study in Brazilian patients. Int J Lepr Other Mycobact Dis 2000; 68: 325-327.
268. Aidoo M, McElroy PD, Kolczak MS et al. Tumor necrosis factor-alpha promoter variant 2 (TNF2) is associated with pre-term delivery, infant mortality, and malaria morbidity in western Kenya: Asembo Bay Cohort Project IX. Genet Epidemiol 2001; 21: 201-211.
269. Tang GJ, Huang SL, Yien HW et al. Tumor necrosis factor gene polymorphism and septic shock in surgical infection. Crit Care Med 2000; 28: 2733-2736.
270. Sarno EN, Santos AR, Jardim MR et al. Pathogenesis of nerve damage in leprosy: genetic polymorphism regulates the production of TNF alpha. Lepr Rev 2000; 71 (Suppl): S154-S158; discussion S158-S160.
271. Brand E, Schorr U, Kunz I et al. Tumor necrosis factor-alpha -308 G/A polymorphism in obese Caucasians. Int J Obes Relat Metab Disord 2001; 25: 581-585.
272. Reid JG, Simpson NA, Walker RG et al. The carriage of proinflammatory cytokine gene polymorphisms in recurrent pregnancy loss. Am J Reprod Immunol 2001; 45: 35-40.
273. Millard TP, Kondeatis E, Cox A et al. A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo. Br J Dermatol 2001; 145: 229-236.
274. Rood MJ, van Krugten MV, Zanelli E et al. TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000; 43: 129-134.
275. Patuzzo C, Gile LS, Zorzetto M et al. Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis. Chest 2000; 117: 1353-1358.
276. Niizeki H, Naruse T, Hashigucci K et al. Polymorphisms in the TNFA promoter region is not associated with palmoplantar pustulosis. Tissue Antigens 2000; 56: 162-165.
277. Shapira L, Stabholz A, Rieckmann P, Kruse N. Genetic polymorphism of the tumor necrosis factor (TNF)-alpha promoter region in families with localized early-onset periodontitis. J Periodontal Res 2001; 36: 183-186.
278. Romeo S, Sentinelli F, Capici F et al. The G-308A variant of the Tumor Necrosis Factor-alpha (TNF-alpha) gene is not associated with obesity, insulin resistance and body fat distribution. BMC Med Genet 2001; 2: 10.
279. Collins JS, Perry RT, Watson Jr B et al. Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative. Am J Med Genet 2000; 96: 823-830.
280. Powell JJ, Fearon KC, Siriwardena AK, Ross JA. Evidence against a role for polymorphisms at tumor necrosis factor, interleukin-1 and interleukin-1 receptor antagonist gene loci in the regulation of disease severity in acute pancreatitis. Surgery 2001; 129: 633-640.
281. McCusker SM, Curran MD, Dynan KB et al. Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet 2001; 357: 436-439.
282. Hamaguchi K, Kimura A, Seki N et al. Analysis of tumor necrosis factor-alpha promoter polymorphism in type 1 diabetes: HLA-B and -DRB1 alleles are primarily associated with the disease in Japanese. Tissue Antigens 2000; 55: 10-16.
283. Kamizono S, Yamada K, Seki N et al. Susceptible locus for obese type 2 diabetes mellitus in the 5′-flanking region of the tumor necrosis factor-alpha gene. Tissue Antigens 2000; 55: 449-452.
284. Tsukasaki K, Miller CW, Kubota T et al. Tumor necrosis factor alpha polymorphism associated with increased susceptibility to development of adult T-cell leukemia/lymphoma in human T-lymphotropic virus type 1 carriers. Cancer Res 2001; 61: 3770-3774.